For 20+ years, Cogstate has proudly supported the leading-edge research needs of biopharmaceutical companies and academic institutions, and the clinical care needs of physicians and patients around the world.
We provide rapid, reliable and highly sensitive computerized cognitive tests and support electronic clinical outcome assessment (eCOA) solutions. We also offer quality assurance services for clinical trial endpoints that combine innovative operational approaches, advanced analytics and scientific consulting.
We provide rapid, reliable and highly sensitive computerized cognitive tests and support electronic clinical outcome assessment (eCOA) solutions. We also offer quality assurance services for clinical trial endpoints that combine innovative operational approaches, advanced analytics and scientific consulting.
Location: Australia, Victoria, Melbourne
Employees: 51-200
Total raised: $1.3M
Founded date: 1999
Investors 1
| Date | Name | Website |
| - | Dolby Fami... | dolbyventu... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 29.04.2020 | - | $1.3M | - |
Mentions in press and media 17
| Date | Title | Description |
| 30.10.2024 | Utilizing the Measurement of Cognition to Determine Drug Safety in Late Phase Clinical Trials, Upcoming Webinar Hosted by Xtalks | www.cogstate.com In this free webinar, explore the considerations for the use of cognition to guide decision-making about drug safety in late-phase trials. Attendees will be shown examples that highlight how detecting change in cognition is... |
| 17.09.2024 | Developmental & Epileptic Encephalopathy (DEE) Trials: Optimizing Endpoints, Determining MCID, and Enhancing Trial Data Quality, Upcoming Webinar Hosted by Xtalks | www.cogstate.com In this free webinar, gain insights into the complex challenges of conducting clinical trials for developmental and epileptic encephalopathy. Attendees will learn about approaches for data collection across large geographic... |
| 10.04.2024 | Using Cognition to Understand Effects of Medicines Used to Optimize Sleep or Wakefulness, Upcoming Webinar Hosted by Xtalks | www.cogstate.com In this free webinar, learn about the importance of measuring cognition in sleep medicine trials. Attendees will gain insights into the nature and magnitude of cognitive impairment that can occur in sleep medicine drug deve... |
| 11.03.2024 | Cognitive Assessment And Training Market Size, Share And Growth Analysis For 2024-2033 | Cognitive Assessment And Training Global Market Report 2024 – Market Size, Trends, And Market Forecast 2024-2033 The Business Research Company’s Cognitive Assessment And Training Global Market Report 2024 – Market Size, Trends, And Market F... |
| 05.04.2023 | Parkinsonian Symptoms — Capturing a Comprehensive Picture with Fit-for-Purpose Assessments, Upcoming Webinar Hosted by Xtalks | The webinar will also include regulatory considerations, such as acceptance, recent digital health technology guidance and approval pathway selection for clinical outcome assessments or biomarker endpoints. TORONTO (PRWEB) April 05, 2023 Th... |
| 28.02.2023 | Improving Data Quality and Reducing Site/Patient Burden in Remote Rare Disease Trials, Upcoming Webinar Hosted by Xtalks | many assessments in rare disease trials are complex, and remote/hybrid trials readily allow for the use of highly expert centralized raters to administer and score the scales, thereby improving data quality via a decrease in variance and an... |
| 01.12.2022 | Bringing the Clinical Trial to the Patient in Preclinical Alzheimer’s Disease, Upcoming Webinar Hosted by Xtalks | Clinical trial teams now need testing solutions that are effective and equivalent when deployed outside of the clinical site. TORONTO, Ontario (PRWEB) December 01, 2022 With the first demonstration that anti-amyloid therapies can slow amylo... |
| 31.05.2022 | Cultural-Linguistic Considerations for Successful Cognitive Endpoint Assessment in International CNS Clinical Trials, Upcoming Webinar Hosted by Xtalks | Gathering valid and reliable data from cognitive testing in international, multi-country clinical trials requires the expert oversight of highly specialized clinicians. TORONTO (PRWEB) May 31, 2022 Cognitive assessment is a powerful tool to... |
| 09.03.2022 | CNS Safety of Drugs in Late Phase Clinical Trials: Using Cognitive Information in Discussions with Regulators, Upcoming Webinar Hosted by Xtalks | In late phase clinical trials, the nature and magnitude of changes in cognition can provide an accurate index of negative CNS effects of the new drugs being studied. TORONTO (PRWEB) March 09, 2022 In clinical trials of new drugs that have d... |
| 15.02.2022 | Leveraging Remote Assessments and Central Raters to Optimize Rare Disease Clinical Trials, Upcoming Webinar Hosted by Xtalks | Using central raters in a clinical trial can provide significant benefits to study teams, particularly by decreasing variance and increasing reliability in the data collected. TORONTO (PRWEB) February 15, 2022 Fully remote or hybrid adminis... |
Show more